Circio Holding ASA (OSL:CRNA)

Norway flag Norway · Delayed Price · Currency is NOK
5.30
+0.28 (5.58%)
At close: Mar 13, 2026
Market Cap1.14B +2,086.7%
Revenue (ttm)n/a
Net Income-6.60M
EPS-0.11
Shares Out214.91M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume28,278,070
Average Volume14,444,668
Open5.12
Previous Close5.02
Day's Range4.70 - 5.84
52-Week Range0.48 - 5.84
Beta1.91
RSI87.76
Earnings DateApr 15, 2026

About Circio Holding ASA

Circio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a collaboration with Certest Biotec, S.L. for formulation of circVec. The company was formerly known as Targovax ASA and changed its name to Circio Holdi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 9
Stock Exchange Oslo Børs
Ticker Symbol CRNA
Full Company Profile

Financial Performance

Financial Statements